Tenders Are Invited For Radioactive Materials – Sale Of 7.7 G Of Radium-226 For Medical Applications

Radioactive Materials – Sale Of 7.7 G Of Radium-226 For Medical Applications. The European Commission, Joint Research Centre (Jrc) In Karlsruhe (Germany) Plans To Sell Approximately 7.7 Grams Of Radium-226 (Ra-226), A Valuable Resource From Its Our Strategic Inventory Utilised For Cutting-Edge Research And Development In Nuclear Medical Applications. This Includes Applications In The Production Of Actinium-225 (Ac-225) For The Use Of Targeted Alpha Therapy. Following A Surge Of Demand For Ac-225, Ra-226 Material Serves As A Crucial Source Material For Producing It As Well As Other Valuable Medical Radioisotopes, Such As Lead-212 (Pb-212). With A Growing Demand And Limited Supply For Ra-226, The Jrc Karlsruhe Wants To Contribute To The Medical Isotope Supply Chain. The Expertise Along With The State-Of-The-Art Assets At Jrc Karlsruhe, Equips It To Contribute Effectively To This Critical Field. This Sale Is Meant To Bolster The Availability Of Ra-226 For Medical Applications And Further The Advancement Of Nuclear Medicine.